SCHEMBL135371

SCHEMBL135371

C#CCO[Si](C)(C)C(C)(C)C

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.32
MAPK1 P28482 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14183631 0.81 DUT (0.39)
SCHEMBL2168948 0.79
SCHEMBL5856510 0.79 DUT (0.38)
SCHEMBL2874681 0.78
SCHEMBL12131495 0.78
SCHEMBL73070 0.76 DUT (0.32)
SCHEMBL5856103 0.76 TSHR (0.38)
SCHEMBL27098148 0.76
SCHEMBL7711987 0.75 DUT (0.30)
SCHEMBL4870509 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 965 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250364558-A1 CONCENTRATION GRADIENT-TYPE NEGATIVE ELECTRODE ACTIVE MATERIAL FOR SECONDARY BATTERY AND METHOD FOR MANUFACTURING SAME SOGANG UNIVERSITY RESEARCH & BUSINESS DEVELOPMENT FOUNDATION (KR) 2025-11-27 US claimed
EP-4413085-A1 SILICON-AND ZINC-CONTAINING COUPLING AGENT FOR CELLULOSIC MATERIAL-POLYMER COMPOSITES Arkema, Inc. (US) 2024-08-14 EP claimed
CN-118318010-A Coupling agents containing silicon and zinc for cellulosic material-polymer composites 阿科玛股份有限公司 2024-07-09 CN claimed
CN-117551155-B Synthesis method of 5'-O-DMT-2' -O-propynyl-uridine 苏州诺维康生物科技有限公司 2024-03-29 CN claimed
CN-117551155-A Synthesis method of 5'-O-DMT-2' -O-propynyl-uridine 苏州诺维康生物科技有限公司 2024-02-13 CN claimed
CN-115490589-B Synthesis method of sex attractant for potato tuber moth 贵州大学 2024-02-09 CN claimed
CN-117510562-A Synthesis method of medical intermediate 2' -O-propynyl-uridine 苏州诺维康生物科技有限公司 2024-02-06 CN claimed
US-11814462-B2 Functionalized cyclic polymers and methods of preparing same UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2023-11-14 US claimed
WO-2023059592-A1 SILICON-AND ZINC-CONTAINING COUPLING AGENT FOR CELLULOSIC MATERIAL-POLYMER COMPOSITES ARKEMA INC. (US) 2023-04-13 WO claimed
US-11539077-B2 Electrolyte additives containing one, two, or more triple-bonded moieties for silicon anode-based li-ion batteries ENEVATE CORPORATION (US) 2022-12-27 US claimed
CN-115000604-A Preparation process of aluminum plastic film for lithium battery outer package 江西永德立新能源有限公司 2022-09-02 CN claimed
WO-2022093792-A1 ELECTROLYTE ADDITIVES CONTAINING ONE, TWO, OR MORE TRIPLE-BONDED MOIETIES FOR SILICON ANODE-BASED BATTERIES ENEVATE CORPORATION (US) 2022-05-05 WO claimed
US-20220131195-A1 ELECTROLYTE ADDITIVES CONTAINING ONE, TWO, OR MORE TRIPLE-BONDED MOIETIES FOR SILICON ANODE-BASED LI-ION BATTERIES ENEVATE CORPORATION 2022-04-28 US claimed
CN-110724151-B Synthesis method of (3, 4-dihydro-2H-pyrano [2,3-b ] pyridine-6-yl) methanol 成都睿智化学研究有限公司 2022-03-04 CN claimed
US-20220056167-A1 Functionalized Cyclic Polymers and Methods of Preparing Same NATIONAL SCIENCE FOUNDATION 2022-02-24 US claimed
US-20220056275-A1 SILICON- AND ZINC-CONTAINING COUPLING AGENT FOR CELLULOSIC MATERIAL-POLYMER COMPOSITES ARKEMA INC. 2022-02-24 US claimed
EP-0827423-B1 FUNCTIONALIZED CHAIN EXTENDED INITIATORS FOR ANIONIC POLYMERIZATION FMC CORP (US) 2007-12-12 EP claimed
US-12637436-B2 Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof Sanford Burnham Prebys Medical Discovery Institute (US) 2026-05-26 US disclosed
WO-1992000972-A1 RENIN INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1992-01-23 WO disclosed
EP-0448078-A2 Substituted amine derivatives having anti-hyperlipemia activity BANYU PHARMACEUTICAL CO., LTD. (JP) 1991-09-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220131195-A1 ELECTROLYTE ADDITIVES CONTAINING ONE, TWO, OR MORE TRIPLE-BONDED MOIETIES FOR SILICON ANODE-BASED LI-ION BATTERIES SELENOI, SIK1, SIK2 POLB 812/4885MAPK1 902/4885HSD17B10 1366/4885
US-11539077-B2 Electrolyte additives containing one, two, or more triple-bonded moieties for silicon anode-based li-ion batteries SELENOI, SIK1, SIK2 POLB 812/4885MAPK1 902/4885HSD17B10 1366/4885
US-12637436-B2 Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof GRM3, GRM2, GRM1 POLB 4385/4885MAPK1 1372/4885HSD17B10 3441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.